Coenzyme Q10 Migraine Meta-analysis: What the Evidence Says

Quick Answer

Coenzyme Q10 Migraine Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Migraine is a chronic, disabling neurovascular disorder characterized by recurrent episodes of moderate-to-severe headache, typically unilateral and pulsating in quality, and frequently associated with nausea, vomiting, photophobia, and phonophobia. [Santangelo Domenico (2026); evidence level 3]
• These processes result in peripheral and central sensitization of nociceptive pathways, thereby amplifying pain perception and contributing to migraine chronicization. [Santangelo Domenico (2026); evidence level 3]
• A growing body of evidence points to a significant link between migraine and disruptions in brain energy metabolism. [Sun Wen-xiu (2025); evidence level 3]
• As a result, prophylactic treatments for migraine that target brain energy metabolism, including riboflavin, coenzyme Q10, alpha-lipoic acid (ALA), and ketogenic diet (KD), have gained increasing attention. [Sun Wen-xiu (2025); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For coenzyme q10 migraine meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Santangelo Domenico (2026). Dietary Modulation of Migraine: Metabolic, Neuroinflammatory and Microbiota-Mediated Mechanisms. DOI: 10.3390/jcm15041476. PMCID: PMC12942355. PMID: 41753160. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12942355/
• Sun Wen-xiu (2025). Energy metabolism disorders in migraine: triggers, pathways, and therapeutic repurposing. DOI: 10.3389/fneur.2025.1561000. PMCID: PMC12002086. PMID: 40242623. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12002086/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.